XTL Biopharmaceuticals Ltd ADR (XTLB)

3.810
+0.070(+1.87%)
Pre Market
3.750
-0.060(-1.57%)
- Real-time Data
  • Volume:
    5,305
  • Bid/Ask:
    3.740/3.990
  • Day's Range:
    3.730 - 3.810

XTLB Overview

Prev. Close
3.74
Day's Range
3.73-3.81
Revenue
-
Open
3.749
52 wk Range
2-6.69
EPS
-0.15
Volume
5,305
Market Cap
20.28M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
100,561
P/E Ratio
-
Beta
1.01
1-Year Change
60.76%
Shares Outstanding
528,156,149
Next Earnings Date
Dec 07, 2021
What is your sentiment on XTL Biopharmaceuticals Ltd ADR?
or
Market is currently closed. Voting is open during market hours.

XTL Biopharmaceuticals Ltd ADR News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellStrong SellNeutral
Technical IndicatorsBuyBuySellStrong SellStrong Buy
SummaryNeutralNeutralSellStrong SellBuy

XTL Biopharmaceuticals Ltd ADR Company Profile

XTL Biopharmaceuticals Ltd ADR Company Profile

Employees
0

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Read More
  • 6 soon
    0
    • I'm in think iits moves depend on Tel Aviv price
      0
      • Anyone around? Why is it blocked?
        0
        • Anyone around?
          0
          • any news, fellas?
            0
            • I can't find any news. Cheers.
              0
              • May have good news on their Lupus drug
                0
                • İs there a reason why this stock is going up?
                  0
                  • I owned this for two month and sold it 1 week before -.-
                    0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.